Export 81 results:
Author Title Type [ Year
Filters: Author is Clemons, Traci E [Clear All Filters]
“Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study.”, Pediatrics, vol. 136, no. 5, pp. 885-94, 2015.
, “Multimodal imaging in type 2 idiopathic macular telangiectasia.”, Retina, vol. 35, no. 4, pp. 742-9, 2015.
, “The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.”, Ophthalmology, vol. 123, no. 4, pp. 916-7, 2016.
, “EFFECTIVENESS OF DIFFERENT MONITORING MODALITIES IN THE DETECTION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Home Study, Report Number 3.”, Retina, vol. 36, no. 8, pp. 1542-7, 2016.
, “Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.”, JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
, “Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research G”, Ophthalmology, vol. 124, no. 4, pp. 479-487, 2017.
, “ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
, “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
, “CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.”, Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
, “CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S27-S32, 2018.
, “Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.”, Br J Ophthalmol, vol. 102, no. 4, pp. 465-472, 2018.
, “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
, “LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.”, Retina, vol. 38 Suppl 1, pp. S20-S26, 2018.
, “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
, “Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”, Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
, “The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”, Ophthalmology, vol. 126, no. 12, pp. 1647-1656, 2019.
, “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
, “Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.”, Ophthalmology, vol. 126, no. 4, pp. 540-549, 2019.
, “Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.”, Ophthalmol Retina, vol. 3, no. 4, pp. 326-335, 2019.
, “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, vol. 126, no. 2, pp. 261-273, 2019.
, “No association between sleep apnoea and macular telangiectasia type 2 and its markers of severity and progression: a case-control study and retrospective cohort study.”, Clin Exp Ophthalmol, vol. 47, no. 1, pp. 63-68, 2019.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
, “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
, “Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.”, Alzheimers Dement, vol. 16, no. 6, pp. 831-842, 2020.
,